The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first‐line therapy for patients with metastatic castration‐resistant prostate cancer
暂无分享,去创建一个
H. Zeng | L. Nie | N. Chen | Xue-qin Chen | Junru Chen | Y. Ni | Sha Zhu | Jinge Zhao | Zhipeng Wang | Haoran Zhang | Xudong Zhu | Xingming Zhang | J. Dai | P. Shen | Jiayu Liang | Zhenhua Liu | Meng-Ni Zhang | G. Sun | Zilin Wang | Ben He | Ronggui Tao | Jindong Dai | Y. Ni | Zilin Wang | Haoran Zhang